These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27154028)

  • 21. Pseudoshikonin I enhances osteoblast differentiation by stimulating Runx2 and Osterix.
    Choi YH; Han Y; Jin SW; Lee GH; Kim GS; Lee DY; Chung YC; Lee KY; Jeong HG
    J Cell Biochem; 2018 Jan; 119(1):748-757. PubMed ID: 28657691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylation of bone SOST, its mRNA, and serum sclerostin levels correlate strongly with fracture risk in postmenopausal women.
    Reppe S; Noer A; Grimholt RM; Halldórsson BV; Medina-Gomez C; Gautvik VT; Olstad OK; Berg JP; Datta H; Estrada K; Hofman A; Uitterlinden AG; Rivadeneira F; Lyle R; Collas P; Gautvik KM
    J Bone Miner Res; 2015 Feb; 30(2):249-56. PubMed ID: 25155887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel variant in Sp7/Osx associated with recessive osteogenesis imperfecta with bone fragility and hearing impairment.
    Fiscaletti M; Biggin A; Bennetts B; Wong K; Briody J; Pacey V; Birman C; Munns CF
    Bone; 2018 May; 110():66-75. PubMed ID: 29382611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanical strain-mediated reduction in RANKL expression is associated with RUNX2 and BRD2.
    Galea GL; Paradise CR; Meakin LB; Camilleri ET; Taipaleenmaki H; Stein GS; Lanyon LE; Price JS; van Wijnen AJ; Dudakovic A
    Gene; 2020 Dec; 763S():100027. PubMed ID: 34493364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Skeletal analysis and differential gene expression in Runx2/Osterix double heterozygous embryos.
    Baek JE; Choi JY; Kim JE
    Biochem Biophys Res Commun; 2014 Aug; 451(3):442-8. PubMed ID: 25111820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of GSK3β Stimulates BMP Signaling and Decreases SOST Expression Which Results in Enhanced Osteoblast Differentiation.
    Schoeman MA; Moester MJ; Oostlander AE; Kaijzel EL; Valstar ER; Nelissen RG; Löwik CW; de Rooij KE
    J Cell Biochem; 2015 Dec; 116(12):2938-46. PubMed ID: 26095393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful induction of sclerostin in human-derived fibroblasts by 4 transcription factors and its regulation by parathyroid hormone, hypoxia, and prostaglandin E2.
    Fujiwara M; Kubota T; Wang W; Ohata Y; Miura K; Kitaoka T; Okuzaki D; Namba N; Michigami T; Kitabatake Y; Ozono K
    Bone; 2016 Apr; 85():91-8. PubMed ID: 26851122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulation of SOST/sclerostin by PTH: a novel mechanism of hormonal control of bone formation mediated by osteocytes.
    Bellido T
    J Musculoskelet Neuronal Interact; 2006; 6(4):358-9. PubMed ID: 17185824
    [No Abstract]   [Full Text] [Related]  

  • 29. Altered MicroRNA Expression Is Responsible for the Pro-Osteogenic Phenotype of Interstitial Cells in Calcified Human Aortic Valves.
    Song R; Fullerton DA; Ao L; Zhao KS; Reece TB; Cleveland JC; Meng X
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28438736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 1α,25-dihydroxyvitamin D3 stimulates human SOST gene expression and sclerostin secretion.
    Wijenayaka AR; Yang D; Prideaux M; Ito N; Kogawa M; Anderson PH; Morris HA; Solomon LB; Loots GG; Findlay DM; Atkins GJ
    Mol Cell Endocrinol; 2015 Sep; 413():157-67. PubMed ID: 26112182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Control of the SOST bone enhancer by PTH using MEF2 transcription factors.
    Leupin O; Kramer I; Collette NM; Loots GG; Natt F; Kneissel M; Keller H
    J Bone Miner Res; 2007 Dec; 22(12):1957-67. PubMed ID: 17696759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LIM Mineralization Protein-1 Enhances Bone Morphogenetic Protein-2-Mediated Osteogenesis Through Activation of ERK1/2 MAPK Pathway and Upregulation of Runx2 Transactivity.
    Pan H; Li X; Wang J; Zhang K; Yang H; Li Z; Zheng Z; Liu H
    J Bone Miner Res; 2015 Aug; 30(8):1523-35. PubMed ID: 25677945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcriptional regulation of bone sialoprotein gene expression by Osx.
    Yang Y; Huang Y; Zhang L; Zhang C
    Biochem Biophys Res Commun; 2016 Aug; 476(4):574-579. PubMed ID: 27261434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Transcriptional Modulator Interferon-Related Developmental Regulator 1 in Osteoblasts Suppresses Bone Formation and Promotes Bone Resorption.
    Iezaki T; Onishi Y; Ozaki K; Fukasawa K; Takahata Y; Nakamura Y; Fujikawa K; Takarada T; Yoneda Y; Yamashita Y; Shioi G; Hinoi E
    J Bone Miner Res; 2016 Mar; 31(3):573-84. PubMed ID: 26391411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Transcription Regulators and Bone Metabolism].
    Hinoi E; Iezaki T; Fukasawa K; Kaneda K
    Yakugaku Zasshi; 2019; 139(1):15-18. PubMed ID: 30606922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple mechanisms are involved in inhibition of osteoblast differentiation by PTHrP and PTH in KS483 Cells.
    van der Horst G; Farih-Sips H; Löwik CW; Karperien M
    J Bone Miner Res; 2005 Dec; 20(12):2233-44. PubMed ID: 16294276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and characterization of microRNAs controlled by the osteoblast-specific transcription factor Osterix.
    Chen Q; Liu W; Sinha KM; Yasuda H; de Crombrugghe B
    PLoS One; 2013; 8(3):e58104. PubMed ID: 23472141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SOST is a target gene for PTH in bone.
    Keller H; Kneissel M
    Bone; 2005 Aug; 37(2):148-58. PubMed ID: 15946907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Nfic-osterix pathway regulates ameloblast differentiation and enamel formation.
    Lee DS; Roh SY; Park JC
    Cell Tissue Res; 2018 Dec; 374(3):531-540. PubMed ID: 30091046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low sirtuin 1 levels in human osteoarthritis subchondral osteoblasts lead to abnormal sclerostin expression which decreases Wnt/β-catenin activity.
    Abed É; Couchourel D; Delalandre A; Duval N; Pelletier JP; Martel-Pelletier J; Lajeunesse D
    Bone; 2014 Feb; 59():28-36. PubMed ID: 24184155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.